Bessemer Securities’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,352
Closed -$589K 42
2023
Q3
$589K Buy
1,352
+15
+1% +$6.8K 0.82% 32
2023
Q2
$594K Sell
1,337
-125
-9% -$57.7K 0.39% 95
2023
Q1
$672K Sell
1,462
-232
-14% -$110K 0.31% 99
2022
Q4
$869K Sell
1,694
-341
-17% -$173K 0.39% 89
2022
Q3
$924K Hold
2,035
0.33% 81
2022
Q2
$982K Hold
2,035
0.34% 83
2022
Q1
$1M Hold
2,035
0.29% 89
2021
Q4
$943K Buy
2,035
+227
+13% +$95.5K 0.26% 85
2021
Q3
$674K Hold
1,808
0.23% 95
2021
Q2
$690K Hold
1,808
0.27% 88
2021
Q1
$649K Buy
1,808
+483
+36% +$155K 0.27% 88
2020
Q4
$425K Hold
1,325
0.18% 62
2020
Q3
$356K Hold
1,325
0.17% 67
2020
Q2
$348K Sell
1,325
-9,628
-88% -$2.57M 0.18% 68
2020
Q1
$2.49M Buy
10,953
+1,325
+14% +$361K 1.23% 10
2019
Q4
$2.91M Sell
9,628
-250
-3% -$68.8K 1.14% 9
2019
Q3
$2.37M Buy
9,878
+1,600
+19% +$438K 0.98% 15
2019
Q2
$2.34M Sell
8,278
-183
-2% -$50K 0.98% 17
2019
Q1
$2.43M Sell
8,461
-660
-7% -$191K 0.83% 21
2018
Q4
$2.4M Buy
+9,121
New +$2.51M 0.9% 18
2015
Q4
Sell
-10,878
Closed -$1.52M 23
2015
Q3
$1.52M Hold
10,878
0.59% 50
2015
Q2
$1.79M Buy
+10,878
New +$1.74M 0.62% 46

Other funds holding ELV

Bessemer Securities's ELV Position: Q4 2023 in Review

Bessemer Securities sold out of Elevance Health (ELV) in Q4 2023, closing a stake of 1,352 shares — an estimated $589K sold.

Bessemer Securities first reported a position in ELV in Q2 2015 and held it in 22 quarters. The position peaked at $2.91M in Q4 2019. 1,655 funds tracked by Wall St. Rank hold ELV as of Q4 2023.

  • Bessemer Securities reported no remaining Elevance Health position as of Q4 2023 after selling out during the quarter.
  • Bessemer Securities sold 1,352 Elevance Health shares in Q4 2023, an estimated $589K.
  • Bessemer Securities first reported a position in Elevance Health in Q2 2015 and held it in 22 quarters.
  • Bessemer Securities's Elevance Health position peaked at $2.91M in Q4 2019.
  • 1,655 funds tracked by Wall St. Rank held Elevance Health as of Q4 2023.

Based on Bessemer Securities's 13F filing for Q4 2023.